ArticleArthritis research & therapy2014

Blocking the janus-activated kinase pathway reduces tumor necrosis factor alpha-induced interleukin-18 bioactivity by caspase-1 inhibition.

Hubert Marotte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.